Exploring X Chromosome Inactivation | Genetics Explained

Sex-linked inheritance involves genes on X or Y chromosomes. X-linked traits show different patterns in males (hemizygous, one X) versus females (two X chromosomes). X-linked dominant traits: heterozygous mothers pass to 50% of each sex; affected fathers pass only to daughters. X-linked recessive traits: carrier mothers pass to 50% of sons (affected) and 50% of daughters (carriers); affected fathers pass only to daughters (carriers). Y-linked traits transmit only father to son. The Y chromosome contains few genes (~30) compared to X (~1500), making Y-linked traits rare.

This comprehensive section covers three types of sex-linked inheritance. X-linked recessive (hemophilia, color blindness) affects males more frequently; females can be carriers. X-linked dominant shows higher female prevalence. Y-linked inheritance only affects males and passes from father to all sons. The instructor demonstrates systematic pedigree analysis: write sex chromosomes, assign genotypes based on phenotype, track allele inheritance, and verify no contradictions exist. Key contradictions include affected fathers with unaffected daughters (rules out X-linked dominant) or affected fathers with unaffected sons (rules out Y-linked).

X-linked inheritance involves sex chromosomes. Males have one X and one Y, so any X-linked allele is expressed. Females have two Xs, allowing them to be homozygous or heterozygous. In X-linked dominant inheritance, all daughters of affected fathers are affected, while sons are unaffected. In X-linked recessive inheritance, affected females must have affected fathers, and all sons of affected females are affected if she is homozygous. Carrier females (X^A X^a) may show half-shading in pedigrees. These patterns create distinct transmission patterns that differ fundamentally from autosomal inheritance.

This segment covers X-linked inheritance patterns. X-linked recessive traits are carried on the X chromosome and more commonly affect males. Females can be carriers without showing the trait. X-linked dominant traits affect both sexes but follow different inheritance patterns. The analysis involves checking if affected males have carrier mothers, if affected females have affected fathers and carrier mothers, and if affected males cannot pass the trait to their sons.

For X-linked recessive inheritance: (1) All males are affected while females are not affected, (2) If a female is affected, her father must be affected, (3) An affected female will have affected sons. This pattern occurs because males have only one X chromosome, so any recessive allele on it will cause the disease. Females need two copies of the recessive allele to be affected.

Gene expression is the process of using genetic information stored in DNA to synthesize proteins. This fundamental biological process involves two sequential stages: transcription and translation. During transcription, the DNA molecule serves as a template to produce RNA molecules. In translation, the RNA molecule directs protein synthesis at the ribosome. The DNA contains the genetic code (genotype), while the resulting protein represents the expressed trait (phenotype). Only specific segments of DNA called genes contain the instructions for making proteins, while the rest of the DNA contains non-coding regions that do not directly specify protein sequences.

Gene expression involves two main processes: transcription and translation. Transcription occurs in the nucleus where RNA polymerase binds to promoter sequences and synthesizes RNA from a DNA template, creating an RNA molecule complementary to the DNA template. Translation occurs in the cytoplasm at ribosomes where mRNA is decoded to synthesize proteins. Translation involves three stages: initiation (ribosome assembly at start codon AUG), elongation (polypeptide chain growth as amino acids are added via tRNA), and termination (chain release at stop codons UAA, UAG, UGA). The genetic code is nearly universal, with 64 codons specifying 20 amino acids plus stop signals.

The central dogma describes the flow of genetic information: DNA is transcribed into RNA, and RNA is translated into protein. Transcription is the first stage where a specific DNA segment is copied into messenger RNA (mRNA) in the nucleus. Translation is the second stage where mRNA is read by ribosomes to assemble amino acids into proteins. Transfer RNA (tRNA) brings specific amino acids to the ribosome, while ribosomal RNA (rRNA) helps combine amino acids to form proteins.

The central dogma describes genetic information flow from DNA to RNA to protein. Transcription converts DNA sequences into complementary RNA molecules within transcription units containing promoters, structural genes, and terminators. In eukaryotes, genes are split into coding exons interrupted by non-coding introns. Transcription produces heterogeneous nuclear RNA (hnRNA) that undergoes processing: a methyl cap is added to the 5' end, a poly-A tail of 200-300 adenines is added to the 3' end, and introns are removed through splicing to join exons. Translation decodes mRNA sequences into amino acid chains using tRNA molecules carrying specific amino acids. Each tRNA has an anti-codon complementary to mRNA codons. Translation occurs at ribosomes where codons are read in triplets, beginning with initiation, proceeding through elongation, and terminating at stop codons (UAA, UAG, UGA). Untranslated regions (UTRs) before start codons and after stop codons regulate translation efficiency. Gene expression is regulated at multiple levels: transcriptional, post-transcriptional, translational, and post-translational.

The central dogma describes the flow of genetic information: DNA makes RNA makes protein. Transcription converts DNA template strands into RNA by RNA polymerase, reading DNA 3' to 5' and synthesizing RNA 5' to 3'. The template strand (non-coding/antisense/minus strand) is transcribed, while the complementary strand (coding/sense/positive strand) has the same sequence as mRNA (except T→U). In prokaryotes lacking nuclei, transcribed RNA is immediately translated by ribosomes, often with multiple ribosomes reading the same mRNA simultaneously as polysomes.

Epigenetics regulates gene activity in a heritable manner without altering the primary DNA sequence, controlling which genes are expressed by modifying histone tails through chemical marks such as acetylation (which generally activates genes by reducing histone-DNA attraction) and methylation (whose effect depends on the specific amino acid residue modified, such as H3K4me typically activating genes while H3K9me and H3K27me typically repressing genes); these modifications create either active or repressed chromatin states that determine tissue identity and can contribute to disease when dysregulated, such as cancer through repression of tumor suppressor genes or activation of oncogenes.

This section defines epigenetics as changes in gene expression without altering DNA sequence itself. Unlike polymorphisms (which change DNA), epigenetics involves methyl groups (from folate metabolism) and acetyl groups (from energy metabolism) that attach to DNA and regulate gene activity. These factors are controlled by diet, B vitamins, eating patterns, stress, sleep, and exercise. Critically, these epigenetic patterns can be inherited through sperm and egg DNA, meaning parental lifestyle choices can affect offspring health. The section presents research showing paternal high-fat diets can silence insulin-producing genes in offspring, while maternal B vitamin supplementation can silence disease-promoting genes in eggs.

While we cannot change the genes inherited from our parents, we can modify their activity through epigenetic mechanisms. Only about 5% of disease-related genetic mutations are fully penetrant, meaning they guarantee the development of disease. The remaining 95% of gene mutations that contribute to disease only increase the risk without guaranteeing illness. This means that lifestyle choices and environmental factors can significantly influence whether genetic predispositions manifest as actual disease. For example, even individuals with high-risk genetic profiles can reduce their disease likelihood through positive lifestyle interventions. This understanding shifts medicine from a deterministic model to one emphasizing prevention and personal agency over health outcomes.

Epigenetics refers to heritable changes in gene expression that occur without alterations to the underlying DNA sequence. These modifications are primarily achieved through chemical changes to histone proteins around which DNA is wrapped, forming chromatin. When chromatin is in an open (decondensed) state, genes are more accessible for transcription and are typically expressed; when chromatin is condensed, genes are silenced. Key enzymes called 'writers' add chemical marks (such as acetyl or methyl groups) to histones, while 'erasers' remove these marks, and 'readers' recognize these modifications to recruit other proteins that either activate or repress gene expression. This system allows cells to respond rapidly to environmental influences and developmental cues, and importantly, unlike genetic mutations, epigenetic changes are reversible, making them promising targets for therapeutic intervention in diseases such as cancer.

Epigenetics studies how gene expression can be regulated without changes to the DNA sequence itself. While environmental factors cannot modify DNA sequence, they can add chemical 'marks' (epigenetic marks) that control whether genes are turned on or off. These marks explain how cells with identical DNA can become specialized tissues like skin or brain cells. Environmental factors such as diet, stress, and ecology can influence gene expression through these mechanisms. During fetal development, epigenetic programming establishes metabolic features necessary for adult life, making this period highly sensitive to environmental influences. This represents a mechanism by which early-life experiences can have long-term biological consequences.